FilingsTodayKorean listed companies with the lowest debt ratio (₩100B+ revenue)
Listed Korean companies ranked from the lowest ratio of total liabilities to equity at their latest fiscal year end, among companies with at least ₩100 billion of revenue and positive equity.
At a glance
1,372 companies have a value for this ranking. BioNote is first at 3%, followed by Hwail Pharm (3%) and Dong SUH Companies (4%).
The 10th company, AUK, is at 7%, and the 100th, Muhak, at 17%.
Of the 100 companies listed below, 49 are on KOSPI and 51 on KOSDAQ.
Top 100
| Rank · Company | Debt-to-equity |
|---|---|
| 1 BioNote KOSPI · 2025 revenue ₩118B | 3% |
| 2 Hwail Pharm KOSDAQ · 2025 revenue ₩101B | 3% |
| 3 Dong SUH Companies KOSPI · 2025 revenue ₩533B | 4% |
| 4 Samyoung Electronics KOSPI · 2025 revenue ₩150B | 4% |
| 5 Syts KOSPI · 2025 revenue ₩175B | 5% |
| 6 Kishin KOSPI · 2025 revenue ₩131B | 6% |
| 7 It's Hanbul KOSPI · 2025 revenue ₩153B | 6% |
| 8 Myungin Pharm KOSPI · 2025 revenue ₩287B | 6% |
| 9 Hyundai Futurenet KOSPI · 2025 revenue ₩265B | 7% |
| 10 AUK KOSPI · 2025 revenue ₩133B | 7% |
| 11 Sung Kwang Bend KOSDAQ · 2025 revenue ₩246B | 7% |
| 12 Sindoh KOSPI · 2025 revenue ₩317B | 8% |
| 13 T&L KOSDAQ · 2025 revenue ₩164B | 8% |
| 14 Humedix KOSDAQ · 2025 revenue ₩170B | 8% |
| 15 CS Holdings KOSPI · 2025 revenue ₩135B | 8% |
| 16 Manyo Factory KOSDAQ · 2025 revenue ₩113B | 8% |
| 17 Spigen Korea KOSDAQ · 2025 revenue ₩464B | 8% |
| 18 LEENO Industrial KOSDAQ · 2025 revenue ₩373B | 8% |
| 19 Hy-Lok KOSDAQ · 2025 revenue ₩215B | 8% |
| 20 Ubiquoss Holdings KOSDAQ · 2025 revenue ₩156B | 9% |
| 21 SK Square KOSPI · 2025 revenue ₩1.41T | 9% |
| 22 Tokai Carbon Korea KOSDAQ · 2025 revenue ₩301B | 9% |
| 23 AceBed KOSDAQ · 2025 revenue ₩317B | 9% |
| 24 Me2on KOSDAQ · 2025 revenue ₩121B | 9% |
| 25 Sewon Precision Industry KOSPI · 2025 revenue ₩179B | 9% |
| 26 Shinyoung Wacoal KOSPI · 2025 revenue ₩185B | 10% |
| 27 Hugel KOSDAQ · 2025 revenue ₩425B | 10% |
| 28 Motonic KOSPI · 2025 revenue ₩280B | 10% |
| 29 Hankook & Company KOSPI · 2025 revenue ₩1.46T | 10% |
| 30 Rayence KOSDAQ · 2025 revenue ₩115B | 10% |
| 31 Youngbo Chemical KOSPI · 2025 revenue ₩120B | 10% |
| 32 Samhyun Steel KOSDAQ · 2025 revenue ₩218B | 10% |
| 33 Suprema KOSDAQ · 2025 revenue ₩137B | 11% |
| 34 T. K KOSDAQ · 2025 revenue ₩297B | 11% |
| 35 KISCO Holdings KOSPI · 2025 revenue ₩825B | 11% |
| 36 Michang OIL IND KOSPI · 2025 revenue ₩405B | 11% |
| 37 Neopharm KOSDAQ · 2025 revenue ₩132B | 11% |
| 38 Cheryong Electric KOSDAQ · 2025 revenue ₩224B | 12% |
| 39 DoubleUGames KOSPI · 2025 revenue ₩720B | 12% |
| 40 Dong IL Steel MFG KOSPI · 2025 revenue ₩147B | 12% |
| 41 MH Materials KOSPI · 2025 revenue ₩153B | 12% |
| 42 Dongil Industries KOSPI · 2025 revenue ₩348B | 12% |
| 43 LG KOSPI · 2025 revenue ₩7.25T | 12% |
| 44 Fursys KOSPI · 2025 revenue ₩358B | 12% |
| 45 Vitzrocell KOSDAQ · 2025 revenue ₩243B | 12% |
| 46 SAM Jung Pulp KOSPI · 2025 revenue ₩149B | 12% |
| 47 Webzen KOSDAQ · 2025 revenue ₩174B | 12% |
| 48 Saeronautomotive Corporration KOSPI · 2025 revenue ₩139B | 12% |
| 49 DIT KOSDAQ · 2025 revenue ₩108B | 12% |
| 50 KIS KOSPI · 2025 revenue ₩487B | 12% |
| 51 DCM KOSPI · 2025 revenue ₩227B | 13% |
| 52 SG KOSPI · 2025 revenue ₩132B | 13% |
| 53 CU Tech KOSDAQ · 2025 revenue ₩217B | 13% |
| 54 LOTTE Fine Chemical KOSPI · 2025 revenue ₩1.75T | 13% |
| 55 Miwon Chemicals KOSPI · 2025 revenue ₩285B | 13% |
| 56 InBody KOSDAQ · 2025 revenue ₩234B | 13% |
| 57 Pungguk Ethanol KOSDAQ · 2025 revenue ₩164B | 13% |
| 58 EO Technics KOSDAQ · 2025 revenue ₩381B | 13% |
| 59 Kctech KOSPI · 2025 revenue ₩383B | 13% |
| 60 Samsung Climate Control KOSPI · 2025 revenue ₩118B | 13% |
| 61 Iljin Diamond KOSPI · 2025 revenue ₩162B | 13% |
| 62 Taekwang Industrial KOSPI · 2025 revenue ₩1.83T | 13% |
| 63 Daehyun KOSPI · 2025 revenue ₩241B | 14% |
| 64 Neptune Company KOSDAQ · 2025 revenue ₩123B | 14% |
| 65 Whanin Pharm KOSPI · 2025 revenue ₩255B | 14% |
| 66 Ubiquoss KOSDAQ · 2025 revenue ₩116B | 14% |
| 67 Purit KOSDAQ · 2025 revenue ₩143B | 14% |
| 68 Korea United Pharm KOSPI · 2025 revenue ₩289B | 14% |
| 69 Wemade Play KOSDAQ · 2025 revenue ₩125B | 14% |
| 70 Taeyang KOSDAQ · 2025 revenue ₩140B | 14% |
| 71 Heungkuk Metaltech KOSDAQ · 2025 revenue ₩137B | 15% |
| 72 Daejung Chemicals & Metals KOSDAQ · 2025 revenue ₩108B | 15% |
| 73 UNID btplus KOSPI · 2025 revenue ₩158B | 15% |
| 74 Samyang KCI KOSDAQ · 2025 revenue ₩117B | 15% |
| 75 Monali KOSPI · 2025 revenue ₩124B | 15% |
| 76 Seowonintech KOSDAQ · 2025 revenue ₩195B | 15% |
| 77 Wiscom KOSPI · 2025 revenue ₩103B | 15% |
| 78 Cymechs KOSDAQ · 2025 revenue ₩164B | 15% |
| 79 Boditech Med KOSDAQ · 2025 revenue ₩162B | 15% |
| 80 Intops KOSDAQ · 2025 revenue ₩591B | 15% |
| 81 HyVISION SYSTEM. KOSDAQ · 2025 revenue ₩171B | 15% |
| 82 Namyang Dairy Products KOSPI · 2025 revenue ₩914B | 15% |
| 83 Poongsan Holdings KOSPI · 2025 revenue ₩433B | 15% |
| 84 PSK Holdings KOSDAQ · 2025 revenue ₩208B | 16% |
| 85 Samyung Trading KOSPI · 2025 revenue ₩447B | 16% |
| 86 Bookook Steel KOSPI · 2025 revenue ₩180B | 16% |
| 87 DaehanPharmaceutical KOSDAQ · 2025 revenue ₩209B | 16% |
| 88 ISC KOSDAQ · 2025 revenue ₩220B | 16% |
| 89 DaelimPaper KOSDAQ · 2025 revenue ₩169B | 16% |
| 90 Union Semiconductor Equipment Co.,ltd; KOSDAQ · 2025 revenue ₩273B | 16% |
| 91 Samjin KOSDAQ · 2025 revenue ₩148B | 16% |
| 92 SFA Semicon KOSDAQ · 2025 revenue ₩367B | 16% |
| 93 Eusu Holdings KOSPI · 2025 revenue ₩418B | 16% |
| 94 Sanil Electric KOSPI · 2025 revenue ₩502B | 16% |
| 95 Sena Technologies KOSDAQ · 2025 revenue ₩179B | 17% |
| 96 Inics KOSDAQ · 2025 revenue ₩123B | 17% |
| 97 Eco Volt KOSDAQ · 2025 revenue ₩217B | 17% |
| 98 HeunguOil KOSDAQ · 2025 revenue ₩108B | 17% |
| 99 Sammok S-Form KOSDAQ · 2025 revenue ₩317B | 17% |
| 100 Muhak KOSPI · 2025 revenue ₩144B | 17% |
How this is calculated
Consolidated figures where available, standalone otherwise. Liabilities include trade payables, advances received and lease liabilities as well as borrowings, so businesses that collect payment in advance can see the ratio rise as sales grow.
A low ratio is not always a strength; it can also mean cash piling up unused.
Source: financial statement data from periodic reports filed with DART. Figures are as filed; this list is not a recommendation to buy or sell any stock.
Other rankings
Average pay · Tenure · Employees · Director pay · Dividend yield · Dividend growth · Revenue growth · Operating margin